CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- 4 Open-market sale President, CEO sold 15,309 shares at $43.26 ($662,267)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,363 shares at $43.26 ($145,483)
- 4 Open-market sale Chief Medical Officer sold 4,219 shares at $43.26 ($182,514)
- 4 Open-market sale CHIEF LEGAL OFFICER sold 2,983 shares at $43.26 ($129,045)
- 4 Open-market sale Director sold 3,900 shares at $49.58 ($193,343)
- 4 Other disposition Director disposed of 11,068 shares (other)
- 4 Planned sale Chief Medical Officer sold 1,500 shares at $50.00 ($75,000)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $50.00 ($500,000)
- 4 Planned sale CHIEF LEGAL OFFICER sold 10,000 shares at $51.00 ($510,000)
- 4 Planned sale CHIEF LEGAL OFFICER sold 22,641 shares at an average $45.38 ($1,027,425)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,725 shares at an average $44.85 ($705,333)
- 4 Planned sale CHIEF LEGAL OFFICER sold 8,240 shares at $29.00 ($238,960)
- 4 Exercise or conversion Director acquired 1,300 shares (option exercise)
- 4 Planned sale Director sold 10,231 shares at an average $19.62 ($200,714)
- 4 Planned sale Director sold 20,925 shares at an average $23.57 ($493,191)
- 4 Planned sale Director sold 3,015 shares at $23.97 ($72,270)
- 4 Planned sale Director sold 3,015 shares at $23.97 ($72,270)
- 4 Exercise or conversion Director acquired 7,330 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
Page 3 of 15 · 298 filings